SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950123-09-057996
Filing Date
2009-11-05
Accepted
2009-11-05 08:07:51
Documents
6
Period of Report
2009-09-30

Document Format Files

Seq Description Document Type Size
1 IDERA PHARMACEUTICALS, INC. b77449e10vq.htm 10-Q 358606
2 EX-10.1 OFFER LETTER, DATED NOVEMBER 27, 2006, AS AMENDED b77449exv10w1.htm EX-10.1 24026
3 EX-31.1 SECTION 302 CERTIFICATION OF CEO b77449exv31w1.htm EX-31.1 5950
4 EX-31.2 SECTION 302 CERTIFICATION OF CFO b77449exv31w2.htm EX-31.2 6236
5 EX-32.1 SECTION 906 CERTIFICATION OF CEO b77449exv32w1.htm EX-32.1 3212
6 EX-32.2 SECTION 906 CERTIFICATION OF CFO b77449exv32w2.htm EX-32.2 2968
  Complete submission text file 0000950123-09-057996.txt   402491
Mailing Address 167 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 167 SIDNEY STREET CAMBRIDGE MA 02139 6176795500
IDERA PHARMACEUTICALS, INC. (Filer) CIK: 0000861838 (see all company filings)

IRS No.: 043072298 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31918 | Film No.: 091159496
SIC: 2836 Biological Products, (No Diagnostic Substances)